Page last updated: 2024-08-24

valsartan and Arterial Occlusive Diseases

valsartan has been researched along with Arterial Occlusive Diseases in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Cui, TX; Horiuchi, M; Iwai, M; Li, JM; Li, Z; Nakagami, H	1

Other Studies

1 other study(ies) available for valsartan and Arterial Occlusive Diseases

Article	Year
Fluvastatin enhances the inhibitory effects of a selective angiotensin II type 1 receptor blocker, valsartan, on vascular neointimal formation. Circulation, 2003, Jan-07, Volume: 107, Issue:1 Topics: Angiotensin Receptor Antagonists; Animals; Arterial Occlusive Diseases; Cell Division; Cells, Cultured; DNA; DNA-Binding Proteins; Drug Synergism; Fatty Acids, Monounsaturated; Fluvastatin; Genes, fos; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Indoles; Male; Mice; Mice, Inbred C57BL; Mitogen-Activated Protein Kinases; Muscle, Smooth, Vascular; Phosphorylation; Receptor, Angiotensin, Type 1; Signal Transduction; Tetrazoles; Valine; Valsartan	2003

Article

Year

Fluvastatin enhances the inhibitory effects of a selective angiotensin II type 1 receptor blocker, valsartan, on vascular neointimal formation.

Circulation, 2003, Jan-07, Volume: 107, Issue:1

Topics: Angiotensin Receptor Antagonists; Animals; Arterial Occlusive Diseases; Cell Division; Cells, Cultured; DNA; DNA-Binding Proteins; Drug Synergism; Fatty Acids, Monounsaturated; Fluvastatin; Genes, fos; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Indoles; Male; Mice; Mice, Inbred C57BL; Mitogen-Activated Protein Kinases; Muscle, Smooth, Vascular; Phosphorylation; Receptor, Angiotensin, Type 1; Signal Transduction; Tetrazoles; Valine; Valsartan

2003